SCHEMBL210371

SCHEMBL210371

Nc1nnnc(Cl)c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210649 0.77 — —
SCHEMBL159747 0.77 — —
SCHEMBL28872864 0.71 — —
SCHEMBL6049955 0.67 CASP1 (0.33) —
SCHEMBL1316316 0.65 — —
SCHEMBL5933484 0.65 — —
SCHEMBL13822465 0.65 — —
SCHEMBL142354 0.63 — —
Sulfurous Acid SCHEMBL5276966 0.63 CA1 (0.33) —
SCHEMBL3622126 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770733-A Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained RHONE MERIEUX (FR) 1998-06-23 — — US claimed
US-5459263-A Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained RHONE MEREIUX (FR) 1995-10-17 — — US claimed
EP-0179408-B1 AMIDOALKYL MELAMINES AND AMINOALKYL MELAMINES, AND PROCESS FOR THEIR PREPARATION BASF Aktiengesellschaft (DE) 1993-09-08 — — EP claimed
EP-0179408-A2 Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation BASF Aktiengesellschaft (DE) 1986-04-30 — — EP claimed
JP-6024960-A — — None — — JP disclosed
US-20160256463-A1 NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS INC (US) 2016-09-08 — — US disclosed
US-9351972-B2 Compounds as respiratory stimulants for treatment of breathing control disorders or diseases GALLEON PHARMACEUTICALS, INC. (US) 2016-05-31 — — US disclosed
CN-103347866-B As the noval chemical compound of the respiratory stimulant for the treatment of control of breathing discomfort or disease GALLEON PHARMACEUTICALS, INC. (US) 2016-05-18 — — CN disclosed
US-20150374706-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS, INC. 2015-12-31 — — US disclosed
US-9162992-B2 Compounds and compositions for treatment of breathing control disorders or diseases GALLEON PHARMACEUTICALS, INC. (US) 2015-10-20 — — US disclosed
US-20150291597-A1 NOVEL ORALLY BIOAVAILABLE BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME GALLEON PHARMACEUTICALS, INC. 2015-10-15 — — US disclosed
EP-2920155-A2 NOVEL ORALLY BIOAVAILABLE BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME Galleon Pharmaceuticals, Inc. (US) 2015-09-23 — — EP disclosed
US-4886882-A URETHANE, AMINOPLAST INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1989-12-12 — — US disclosed
EP-0240867-A1 Process for the preparation of aminoalkyl- or -arylmelamines BASF Aktiengesellschaft (DE) 1987-10-14 — — EP disclosed
EP-0225433-A2 Hydroxyoxaalkyl melamines, process for their preparation and their use BASF Aktiengesellschaft (DE) 1987-06-16 — — EP disclosed
US-4670558-A POLYURETHANE INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0079037-B1 BIS-MELAMINES Degussa Aktiengesellschaft (DE) 1986-10-29 — — EP disclosed
EP-0179408-A2 Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation BASF Aktiengesellschaft (DE) 1986-04-30 — — EP disclosed
EP-0079774-B1 INHIBITING THE ANTAGONISM BETWEEN PYRIDYLOXYPHENOXY ALKANOATE HERBICIDES AND BENZOTHIADIAZINONE HERBICIDES IN POST-EMERGENT APPLICATIONS THE DOW CHEMICAL COMPANY (US) 1985-09-18 — — EP disclosed
EP-0079037-A2 Bis-melamines Degussa Aktiengesellschaft (DE) 1983-05-18 — — EP disclosed
Send feedback